Sponsor of the Day:
Jerkmate
https://www.genoway.com/product/catalog-categories/humanized-mouse
Human Immune System Mouse Strains | genO-BRGSF-(A2)-HIS Models | genOway
Jun 30, 2025 - genO-BRGSF mice are excellent recipients of human CD34+ cells. We routinely generate human immune system mice, using human hematopoietic progenitor cells.
immune systemhumanmousestrainsgeno
https://genoway.webflow.io/legal-notice
Legal notice | genOway
Terms of use, privacy, credits, etc.
legal noticegenoway
https://www.latribune.fr/article/regions/auvergne-rhone-alpes/15375891694839/la-biotech-genoway-compte-renouer-avec-la-croissance-grace-a-lasie
La biotech Genoway compte renouer avec la croissance grâce à l'Asie
Après une année de transformation qui a impacté son résultat net, la biotech lyonnaise GenOway qui développe des modèles précliniques entend renouer avec une...
la biotechrenouer avecgenowaycomptecroissance
https://www.genoway.com/company/corporate-overview
Corporate overview - company profile & board of directors | genOway
genOway (NYSE Alternext: ALGEN) is a public company offering preclinical models and solutions to bio-pharmaceutical and academic researchers for ultimate...
corporate overviewcompany profileboarddirectorsgenoway
https://genoway.webflow.io/company/careers
We are hiring | Recruitment | genOway
We are looking for the right people to join our passionate team of dedicated people. To support our growth, we welcome highly motivated people.
hiring recruitmentgenoway
https://genoway.webflow.io/solutions/pharmacokinetic-biodistribution
Preclinical PK analysis | genOway
preclinicalpkanalysisgenoway
https://www.genoway.com/technologies/rmce
RMCE Technology | Your solution to swap large gene segments | genOway
Feb 5, 2024 - Recombinase-mediated cassette exchange enables the swapping of large genomic regions and is recommended for the generation of humanized models.
technologysolutionswaplargegene
https://genoway.webflow.io/technologies/crispr-cas9-gene-editing
CRISPR/Cas9 Editing Technology | All about this solution | genOway
Jan 26, 2024 - CRISPR/Cas9: structure, mechanisms of action, efficacy, off-target activity, genetic backgrounds, multi-targeting, point-mutations, and large deletions.
crispr cas9editing technologysolutiongenoway